Go to the profile of Noveome Biotherapeutics

Noveome Biotherapeutics

 
  • +1.412.402.9914
  • Networkers
  • United States of America

About Noveome Biotherapeutics

Noveome is a clinical-stage biopharmaceutical company advancing ST266— a first-of-its-kind, multi-targeted secretome containing hundreds of biologically active proteins and other factors crucial to neuroprotection, the modulation of inflammation, cell recovery and healing. ST266 contains physiologic levels of hundreds of active biomolecules, including growth factors and cytokines. These molecules modulate a host of biological pathways, including anti-inflammatory and neuroprotective mechanisms, critical to healing.

Therapeutic Areas

Inflammation

Technologies

Regenerative medicine

Company Type

Biotechnology – R&D services

State of Ownership

Private

Sponsorship Group

Networker

Topics

Editions participated in:

December 2019